NCT01895959 - To Look at the Characteristics of Synovial Fluid and Cartilage Matrix in Osteoarthritic Knee After Hyaluronic Acid Injection | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

November 30, 2016

Study Completion Date

January 31, 2017

Conditions

Knee Osteoarthritis

Interventions

DRUG

Euflexxa

Euflexxa will be injected weekly for 3 consecutive weeks on the knee joint.

DEVICE

Magnetic Resonance Imaging (MRI)

MRI of the knee will be acquired during baseline (a week prior to the treatment), follow up visit 1 (1 week after treatment) and follow up visit 2 (3 months after treatment).

Trial Locations (1)

94107

UCSF - China Basin Imaging Center, San Francisco